Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine Infusion in Migraine and Healthy Volunteers
NCT04577443Completed
- Sponsor
- Dansk Hovedpinecenter
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial of adenosine in migraine, sponsored by Dansk Hovedpinecenter. Primary endpoint: Occurrence and change of migraine attack at 12 hours. Started Nov 2020; status: completed.
02
Drugs
adenosine
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04577443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04577443.